{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T13:57:44Z","timestamp":1721656664762},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T00:00:00Z","timestamp":1332892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1756-0500-5-167","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T14:14:42Z","timestamp":1332944082000},"source":"Crossref","is-referenced-by-count":12,"title":["Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria"],"prefix":"10.1186","volume":"5","author":[{"given":"Akinsegun A","family":"Akinbami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olajumoke O","family":"Oshinaike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owolabi A","family":"Dosunmu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Titilope A","family":"Adeyemo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adewumi","family":"Adediran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulaiman","family":"Akanmu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kikelomo O","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seun","family":"Ilori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinsley","family":"Aile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,28]]},"reference":[{"key":"1545_CR1","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1056\/NEJM200205303462202","volume":"346","author":"AS Lok","year":"2002","unstructured":"Lok AS: Chronic hepatitis B. N Eng J Med. 2002, 346: 1682-1683. 10.1056\/NEJM200205303462202.","journal-title":"N Eng J Med"},{"key":"1545_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0891-5245(99)90001-9","volume":"13","author":"MJ Ott","year":"1999","unstructured":"Ott MJ, Aruda M: Hepatitis B vaccine. J Pediatr Health Care. 1999, 13: 211-6. 10.1016\/S0891-5245(99)90001-9.","journal-title":"J Pediatr Health Care"},{"key":"1545_CR3","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1053\/jhep.2001.29401","volume":"34","author":"AS Lok","year":"2001","unstructured":"Lok AS, McMahon BJ: Chronic hepatitis B. Hepatology. 2001, 34: 1225-41. 10.1053\/jhep.2001.29401.","journal-title":"Hepatology"},{"key":"1545_CR4","unstructured":"World Health Organization fact sheets no: 2004, available at \n                    http:\/\/who.int\/mediacentre\/factsheets\/fs204\/en"},{"key":"1545_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1089-3261(05)70064-7","volume":"3","author":"JN Zuckerman","year":"1999","unstructured":"Zuckerman JN, Zuckerman AJ: The epidemiology of hepatitis B. Clin Liver Dis. 1999, 3: 179-187. 10.1016\/S1089-3261(05)70064-7.","journal-title":"Clin Liver Dis"},{"key":"1545_CR6","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/0035-9203(81)90133-4","volume":"75","author":"YM Fakunle","year":"1981","unstructured":"Fakunle YM, Abdurahman MB, Whittle HC: Hepatitis B virus Infection in Children and Adults in Northern Nigeria: a preliminary Survey. Trans Roy Soc Trop Med Hyg. 1981, 75: 626-629. 10.1016\/0035-9203(81)90133-4.","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"1545_CR7","first-page":"27","volume":"17","author":"PO Abiodun","year":"1990","unstructured":"Abiodun PO, Omoike IU: Hepatitis B surface Antigenaemia in children in Benin City Nigeria. Nig J Paediatr. 1990, 17: 27-31.","journal-title":"Nig J Paediatr"},{"issue":"5\/6","key":"1545_CR8","first-page":"133","volume":"11","author":"EA Ayoola","year":"1986","unstructured":"Ayoola EA, Adelaja AB: Sub-determinants and incidence of Hepatitis B antigen in carriers of HBsAg. Nig Med Practitioner. 1986, 11 (5\/6): 133-136.","journal-title":"Nig Med Practitioner"},{"issue":"3","key":"1545_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/ije\/5.3.279","volume":"5","author":"EA Olumide","year":"1976","unstructured":"Olumide EA: The distribution of HbsAg in Africa and the Tropics: Report of a population study in Nigeria. Int J Epidemiol. 1976, 5 (3): 279-289. 10.1093\/ije\/5.3.279.","journal-title":"Int J Epidemiol"},{"key":"1545_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/jhep.2002.34734","volume":"36","author":"WR Kim","year":"2002","unstructured":"Kim WR, Brown RS, Terrault NA, El-Seragg HH: Burden of liver disease in the United States: summary of a worhshop. Hepatology. 2002, 36: 227-242.","journal-title":"Hepatology"},{"key":"1545_CR11","first-page":"43","volume":"11","author":"JA Smith","year":"1972","unstructured":"Smith JA, Francis TI, Uriri NO: Australian antigen in blood donors in Ibadan, Nigeria: prevalence and genetic studies. Ghana Med J. 1972, 11: 43-49.","journal-title":"Ghana Med J"},{"key":"1545_CR12","first-page":"127","volume":"4","author":"BB Tribedi","year":"1974","unstructured":"Tribedi BB: Australian Antigen in blood donors in Zaria. Nig Med J. 1974, 4: 127-131.","journal-title":"Nig Med J"},{"key":"1545_CR13","first-page":"885","volume":"62","author":"PO Abiodun","year":"1985","unstructured":"Abiodun PO, Ihongbe JC, Ubaru R: HBsAg and Blood donors in Benin City, Nigeria. East Afr Med J. 1985, 62: 885-887.","journal-title":"East Afr Med J"},{"key":"1545_CR14","first-page":"127","volume":"4","author":"IOK Udeozo","year":"1974","unstructured":"Udeozo IOK, Ele E: The Prevalence of Australian Antigenaemia in Enugu, Nigeria. Nigeria Med J. 1974, 4: 127-132.","journal-title":"Nigeria Med J"},{"key":"1545_CR15","first-page":"336","volume":"13","author":"OA Ejele","year":"2004","unstructured":"Ejele OA, Ojule AC: The prevalence of hepatitis b surface Antigen (HBsAg) among prospective blood donors and patients in Port Harcourt, Nigeria. Niger J Med. 2004, 13: 336-338.","journal-title":"Niger J Med"},{"key":"1545_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem D, Prince AM: Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med. 2004, 350: 11-10.1056\/NEJMoa035144.","journal-title":"N Engl J Med"},{"key":"1545_CR17","volume-title":"Pathological basis of Disease: 6th edition","author":"Vinay Kumar","year":"2002","unstructured":"Vinay Kumar , Abul KA, Fausto N, Robins and Contran: Pathological basis of Disease: 6th edition. Edited by: John F. 2002, Elsevier Inc 2005,1600, Kennedy Boulverd, Suite 1800, Philadephia, PA 19103-2899, USA"},{"key":"1545_CR18","first-page":"1","volume":"10","author":"S Ijeoma","year":"2010","unstructured":"Ijeoma S, Nwokediuko , Onyenekwe B, Ijeoma C: Low prevalence of hepatitis Be antigen in asymptomatic adult subjects with hepatitis B virus infection in Enugu, south east Nigeria. Internet J Gastroentorol. 2010, 10: 1-","journal-title":"Internet J Gastroentorol"},{"key":"1545_CR19","first-page":"196","volume":"24","author":"JA Otegbayo","year":"2003","unstructured":"Otegbayo JA, Fasola FA, Abia A: Prevalence of hepatitis B surface and e- antigens, risk factors for virus acquisition and serum transaminase among blood donors in Ibadan. Nigeria Trop Gastroenterol. 2003, 24: 196-197.","journal-title":"Nigeria Trop Gastroenterol"},{"key":"1545_CR20","first-page":"171","volume":"13","author":"PO Abiodun","year":"1994","unstructured":"Abiodun PO, Olomu A, Okolo SN, Obasohan A, Freeman O: The prevalence of Hepatitis Be antigen and anti HBe in adults in Benin City. West Afr J Med. 1994, 13: 171-174.","journal-title":"West Afr J Med"},{"key":"1545_CR21","volume-title":"Statistical Power analysis for behavioural sciences. 2nd edition","author":"J Cohen","year":"1998","unstructured":"Cohen J: Statistical Power analysis for behavioural sciences. 2nd edition. 1998, Lawrence Erlbaum Associates, Hillsdale NJ"},{"issue":"1","key":"1545_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1086\/524074","volume":"46","author":"E Sagnelli","year":"2008","unstructured":"Sagnelli E, Stroffolini T, Mele A, Imparato M, Almasio P: Chronic Hepatitis B in Italy: new features of an old disease. Approaching the universal prevalence of Hepatitis Be Antigen negative cases and the eradication of Hepatitis D infection. Clin Infec Dis. 2008, 46 (1): 110-113. 10.1086\/524074.","journal-title":"Clin Infec Dis"},{"key":"1545_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1046\/j.1365-2893.2002.00304.x","volume":"9","author":"ML Funk","year":"2002","unstructured":"Funk ML, Roseberg DM, Lok AS: Worldwide epidermiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat. 2002, 9: 52-61. 10.1046\/j.1365-2893.2002.00304.x.","journal-title":"J Viral Hepat"},{"issue":"13","key":"1545_CR24","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/hep.510310330","volume":"3","author":"HL Chan","year":"2000","unstructured":"Chan HL, Leung NW, Hussain M, Wong ML, Lok AS: Hepatitis Be antigen negative chronic hepatitis in Hong Kong. Hepatology. 2000, 3 (13): 763-764.","journal-title":"Hepatology"},{"key":"1545_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-2003-37584","volume":"23","author":"SJ Hadziyannis","year":"2003","unstructured":"Hadziyannis SJ, Papatheodoridis GC, Vassilopoulos D: Traetment of HBeAg-negative chronic hepatitis B. Semin Live Dis. 2003, 23: 81-88. 10.1055\/s-2003-37584.","journal-title":"Semin Live Dis"},{"key":"1545_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1046\/j.1365-2893.1998.00109.x","volume":"5","author":"A Laras","year":"1998","unstructured":"Laras A, Koskinas J, Avigidis K, et al: Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e anigen-negative patients. J Viral Hepat. 1998, 5: 241-248. 10.1046\/j.1365-2893.1998.00109.x.","journal-title":"J Viral Hepat"},{"key":"1545_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1055\/s-2003-37590","volume":"23","author":"G Fattovich","year":"2003","unstructured":"Fattovich G: Natural history and prognosis of hepatitis B. Semin Liver Dis. 2003, 23: 47-58.","journal-title":"Semin Liver Dis"},{"key":"1545_CR28","first-page":"180","volume":"17","author":"NS Sheikh","year":"2011","unstructured":"Sheikh NS, Sheikh AS, Sheikh AA, Yahya S, Rafi-U-Shan , Lateef M: Sero-prevalence of Hepatitis B Virus infection in Balochistan province of Pakistan. Saudi. J Gastroenterol. 2011, 17: 180-4.","journal-title":"J Gastroenterol"},{"key":"1545_CR29","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1136\/bmj.287.6401.1254","volume":"287","author":"C Lavarini","year":"1983","unstructured":"Lavarini C, Farci P, Chiaberge E, Veglio E, Giarcbbiet D, et al: IgM antibody against hepatitis B core antigen (IgM anti-HBc): diagnostic and prognostic significance in acute HBsAg positive hepatitis. Brit Med J. 1983, 287: 1254-1256. 10.1136\/bmj.287.6401.1254.","journal-title":"Brit Med J"},{"issue":"1","key":"1545_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jiph.2010.11.003","volume":"4","author":"AA Bawazir","year":"2011","unstructured":"Bawazir AA, Parry CM, Hart CA, Sallam TA, Beeching N: Seroepidermiology and risk factors of hepatitis B virus in Aden, Yemen. J Infec Pub Health. 2011, 4 (1): 48-54. 10.1016\/j.jiph.2010.11.003.","journal-title":"J Infec Pub Health"},{"issue":"8","key":"1545_CR31","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1111\/j.1537-2995.2010.03056.x","volume":"51","author":"DH Seo","year":"2011","unstructured":"Seo DH, Whang DH, Song EY, Kim HS, Park Q: Prevalence of antibodies of hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Transfusion. 2011, 51 (8): 1840-1846. 10.1111\/j.1537-2995.2010.03056.x.","journal-title":"Transfusion"},{"issue":"6","key":"1545_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1365-3148.2010.01021.x","volume":"20","author":"W Antar","year":"2010","unstructured":"Antar W, Elholary MH, Abd EL, Hamid WA, Helmy MF: Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg. Trans Med. 2010, 20 (6): 409-413. 10.1111\/j.1365-3148.2010.01021.x.","journal-title":"Trans Med"},{"issue":"8","key":"1545_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ejim.2007.07.001","volume":"18","author":"D Findik","year":"2007","unstructured":"Findik D, Arslan U, Baykan M: Determination of hepatitis B virus DNA incidence, viral load, and mutations in blood donors with HBsAg-negative serology and antibodies to hepatitis B core antigen. Eur J Intern Med. 2007, 18 (8): 571-5. 10.1016\/j.ejim.2007.07.001.","journal-title":"Eur J Intern Med"},{"key":"1545_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","volume":"11","author":"D Lavanchy","year":"2004","unstructured":"Lavanchy D: Hepatitis B virus epidermiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004, 11: 97-107. 10.1046\/j.1365-2893.2003.00487.x.","journal-title":"J Viral Hepat"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-5-167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-0500-5-167\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-5-167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T07:49:51Z","timestamp":1548143391000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-5-167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,28]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1545"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-5-167","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,28]]},"article-number":"167"}}